DaVita Operating Expenses 2010-2024 | DVA

DaVita annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • DaVita operating expenses for the quarter ending September 30, 2024 were $2.729B, a 3.94% increase year-over-year.
  • DaVita operating expenses for the twelve months ending September 30, 2024 were $10.752B, a 2.96% increase year-over-year.
  • DaVita annual operating expenses for 2023 were $10.537B, a 2.6% increase from 2022.
  • DaVita annual operating expenses for 2022 were $10.271B, a 4.58% increase from 2021.
  • DaVita annual operating expenses for 2021 were $9.821B, a 0.35% decline from 2020.
DaVita Annual Operating Expenses
(Millions of US $)
2023 $10,537
2022 $10,271
2021 $9,821
2020 $9,856
2019 $9,745
2018 $9,879
2017 $9,064
2016 $8,678
2015 $8,845
2014 $10,980
2013 $10,214
2012 $6,889
2011 $5,577
2010 $5,226
2009 $5,161
DaVita Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $2,729
2024-06-30 $2,680
2024-03-31 $2,587
2023-12-31 $2,756
2023-09-30 $2,625
2023-06-30 $2,595
2023-03-31 $2,561
2022-12-31 $2,661
2022-09-30 $2,637
2022-06-30 $2,494
2022-03-31 $2,479
2021-12-31 $2,555
2021-09-30 $2,463
2021-06-30 $2,426
2021-03-31 $2,377
2020-12-31 $2,524
2020-09-30 $2,486
2020-06-30 $2,470
2020-03-31 $2,376
2019-12-31 $2,436
2019-09-30 $2,526
2019-06-30 $2,381
2019-03-31 $2,403
2018-12-31 $2,433
2018-09-30 $2,558
2018-06-30 $2,449
2018-03-31 $2,439
2017-12-31 $2,631
2017-09-30 $2,370
2017-06-30 $2,308
2017-03-31 $1,755
2016-12-31 $-838
2016-09-30 $2,911
2016-06-30 $3,389
2016-03-31 $3,216
2015-12-31 $-477
2015-09-30 $3,016
2015-06-30 $2,954
2015-03-31 $3,352
2014-12-31 $2,876
2014-09-30 $2,814
2014-06-30 $2,688
2014-03-31 $2,602
2013-12-31 $2,579
2013-09-30 $2,623
2013-06-30 $2,350
2013-03-31 $2,663
2012-12-31 $2,090
2012-09-30 $1,605
2012-06-30 $1,666
2012-03-31 $1,529
2011-12-31 $1,396
2011-09-30 $1,439
2011-06-30 $1,415
2011-03-31 $1,327
2010-12-31 $1,172
2010-09-30 $1,393
2010-06-30 $1,345
2010-03-31 $1,317
2009-12-31 $1,322
2009-09-30 $1,329
2009-06-30 $1,283
2009-03-31 $1,227
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.272B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.419B 12.35
Quest Diagnostics (DGX) United States $17.788B 18.03
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
Elanco Animal Health (ELAN) United States $6.955B 16.55
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
Amedisys (AMED) United States $3.166B 22.54
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Aveanna Healthcare Holdings (AVAH) United States $1.127B 0.00
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00